Israel vs Other small states: Immunization, Hib3
Israel
98.0%
in 2024
Other small states
85.6%
in 2024
Israel rank
20th
Other small states rank
18th
Immunization, Hib3 over time
- Israel
- Other small states
How they compare
Israel currently reports 98.0% against 85.6% in Other small states, a difference of 12.4%.
That makes Israel's figure about 1.1 times Other small states's.
Across all 31 years both countries report, Israel has been ahead every year.
Israel ranks 20th and Other small states ranks 18th of 191 countries.
Israel has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Israel | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 92.7% | 3.9% | 88.8% | Israel |
| 2000s | 93.8% | 21.7% | 72.1% | Israel |
| 2010s | 95.7% | 83.1% | 12.6% | Israel |
| 2020s | 98.0% | 85.3% | 12.7% | Israel |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Israel or Other small states?
- Israel, at 98.0% against 85.6% in Other small states as of 2024.
- What is the difference in immunization, hib3 between Israel and Other small states?
- 12.4%, with Israel ahead.
- How many years of comparable data are there for Israel and Other small states?
- 31 years are reported by both, from 1994 to 2024.
- How do Israel and Other small states rank globally for immunization, hib3?
- Israel ranks 20th and Other small states ranks 18th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.